These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 32952830

  • 1. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
    Zgaya R, Ghadhab I, Triki MA, Briki R.
    Pan Afr Med J; 2020; 36():186. PubMed ID: 32952830
    [Abstract] [Full Text] [Related]

  • 2. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG.
    PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P, Biswas J, Mandal A.
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
    Shrestha A, Dongol A, Chawla CD, Adhikari RK.
    Kathmandu Univ Med J (KUMJ); 2011 Feb; 9(33):8-12. PubMed ID: 22610801
    [Abstract] [Full Text] [Related]

  • 11. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage.
    Fawole AO, Sotiloye OS, Hunyinbo KI, Umezulike AC, Okunlola MA, Adekanle DA, Osamor J, Adeyanju O, Olowookere OO, Adekunle AO, Singata M, Mangesi L, Hofmeyr GJ.
    Int J Gynaecol Obstet; 2011 Feb; 112(2):107-11. PubMed ID: 21130446
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I, Williams H, Price M, Pickering K, Merriel A, Tobias A, Lissauer D, Gee H, Tunçalp Ö, Gyte G, Moorthy V, Roberts T, Deeks J, Hofmeyr J, Gülmezoglu M, Coomarasamy A.
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [Abstract] [Full Text] [Related]

  • 19. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO, Ijaiya MA, Saidu R, Aboyeji AP, Jimoh AA, Adesina KT, Abdul IF.
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.